Revvity (RVTY) Prix de l'Action, Cotation, Actualités et Historique | Benzinga

Revvity Inc (RVTY) Prix de l'Action, Cotation, Actualités et Historique

RVTYNYSE

Trade with Public

Trade with Public

$152.64

-2.07-1.34%

Dern. MÀJ: Oct 16, 4:44 PM

$152.64

-2.07-1.34%

AperçuActualités Prévisions de résultats Événements Objectifs de cours Données financières Sentiment Actionnariat Dividendes Comparer Options Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

Statistiques Clés

Ouverture

-

Clôture

$152.64

Volume / Moy.

8.00 / 1.81M

Fourchette Journalière

- - -

Plage 52 Sem.

81.22 - 166.25

Capitalisation Boursière

$17.03B

Ratio P/E

73.38

Rendement des Dividendes

0.18%

Échange

NYSE

RSI

61

Intérêt à Découvert

8.46%

Jours pour Couvrir

2.42

Actualités Récentes de Revvity, Inc.

Revvity Nears 52-Week High, but This Analyst Thinks Stock Can Climb Another 20%

William Blair initiates Revvity (RVTY) at Outperform, citing AI tailwinds, life sciences recovery, and potential 20%+ stock upside.

Vandana Singh

Fed Raises Rates, Yields Hit 2007 Highs as Fuel Costs Set Records: This Week On Wall Street

The Fed hiked for the first time since 2023; the 10-year yield touched 5.04%, and record diesel prices hit truckers and automakers.

Piero Cingari

10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today

The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi pipeline outages, pressuring stocks ahead of the Fed.

Piero Cingari

Revvity Bets on GLP-1 Boom With Human Cell Design Acquisition

Revvity buys Human Cell Design to expand diabetes and GLP-1 drug discovery tech. Acquisition expected to close in Q4 2026.

Vandana Singh

Packaging Corp Of America To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday

Needham analyst Rick Patel maintained a Buy rating. Steven Madden shares closed at $47.27 on Friday. Top analysts change outlook on BTSG, CELC, ESS, CORT, PKG, PRU, RVTY, and SHOO. See how they rate these stocks on Benzinga's analyst ratings page.

Avi Kapoor

Données financières

Trimestriel

Annuel

Nom

Revenu Changement
Brut Changement
EBITDA Changement
EBIT Changement
Bénéfices Changement

Flux de Trésorerie

Flux de Trésorerie Opérationnel (TTM)

627.63M

Flux de Trésorerie d'Investissement (TTM)

-83.26M

Flux de Trésorerie de Financement (TTM)

-503.44M

Flux de Trésorerie Libre (TTM)

558.11M

Dépenses en Capital (TTM)

-69.52M

Variation Nette de la Trésorerie (TTM)

40.94M

Tendances et prévisions des analystes

1

juil.

1

août

1

1

sept.

2

1

oct.

Acheter

Conserver

Vendre

Vente forte

Évaluation et prévisions des analystes

3.0

Conserver

Achat fort

Acheter

Conserver

Vendre

Vente forte

Métriques de Valorisation

Valeur Entreprise

$19.35B

Ratio P/E (TTM)

73.38

Ratio P/E (FWD)

25.97

Ratio PEG (TTM)

-

Ratio P/S (TTM)

5.92

Ratio P/B (TTM)

2.36

Rendement des Bénéfices % (TTM)

1.36%

Rendement des Bénéfices % (FWD)

3.85%

EV / EBITDA (TTM)

25.06

Prix / EBITDA (TTM)

22.35

Prix / Flux de Trésorerie Libre (TTM)

30.91

Valeur Comptable / Action

$64.78

Dette Entreprise

Dette Totale

$3.21B

Dette à Long Terme

$2.63B

Émission de Dette à Long Terme (TTM)

-

Remboursement de la Dette à Long Terme (TTM)

-$418.00K

Trésorerie Totale

$1.02B

Dette sur Capitaux Propres

0.46

Émission de Dette (TTM)

-$418.00K

Remboursement de la Dette (TTM)

-$418.00K